AAAAAA
Results: 26-37/37
Authors:
Maier, G
Bing, G
Falken, U
Wagner, E
Unger, C
Citation: G. Maier et al., Antitumor activity and induction of apoptosis by water-soluble derivativesof 7 beta-hydroxycholesterol in human colon carcinoma cell lines, ANTICANC R, 19(5B), 1999, pp. 4251-4256
Authors:
Ergezinger, K
Vehmeyer, K
Unger, C
Citation: K. Ergezinger et al., Stimulation of human hematopoietic progenitor cells by the alkylphosphocholines hexadecylphosphocholine and hexadecyl-N,N,N-trimethyl-hexanolamine, ANTICANC R, 19(4B), 1999, pp. 3213-3219
Authors:
Hellmark, T
Segelmark, M
Unger, C
Burkhardt, H
Saus, J
Wieslander, J
Citation: T. Hellmark et al., Identification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease, KIDNEY INT, 55(3), 1999, pp. 936-944
Authors:
Drevs, J
Unger, C
Citation: J. Drevs et C. Unger, Influence of enzyme preparations on coagulation and metastasis of malignant tumors, INTERNIST, 40(7), 1999, pp. 806-807
Authors:
Kraft, A
Weindel, K
Ochs, A
Marth, C
Zmija, J
Schumacher, P
Unger, C
Marme, D
Gastl, G
Citation: A. Kraft et al., Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease, CANCER, 85(1), 1999, pp. 178-187
Authors:
Hauns, B
Haring, B
Kohler, S
Mross, K
Robben-Bathe, P
Unger, C
Citation: B. Hauns et al., Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC)in patients with pancreatic cancer, ARZNEI-FOR, 49(12), 1999, pp. 1030-1034
Authors:
Perkins, DN
Unger, C
Citation: Dn. Perkins et C. Unger, Teaching and learning for understanding, INSTRUCTIONAL-DESIGN THEORIES AND MODELS, VOL II, 1999, pp. 91-114
Authors:
Unger, C
Arends, J
Citation: C. Unger et J. Arends, Complementary treatment approaches in tumours of the head and neck region, LARY RH OTO, 77(11), 1998, pp. 627-630
Authors:
Mross, K
Berdel, WE
Fiebig, HH
Velagapudi, R
von Broen, IM
Unger, C
Citation: K. Mross et al., Clinical and pharmacologic phase I study of Cemadotin-HCl (LU103793), a novel antimitotic peptide, given as 24-hour infusion in patients with advanced cancer, ANN ONCOL, 9(12), 1998, pp. 1323-1330
Authors:
Kaufmann-Kolle, P
Klenner, T
Unger, C
Eibl, H
Citation: P. Kaufmann-kolle et al., Liposomal alkylphosphocholines, DRUGS TODAY, 34, 1998, pp. 107-115
Authors:
Unger, C
Maniera, T
Kaufmann-Kolle, P
Eibl, H
Citation: C. Unger et al., In vivo antileishmanial activity of hexadecylphosphocholine and other alkylphosphocholines, DRUGS TODAY, 34, 1998, pp. 133-140
Authors:
Rostock, M
Unger, C
Citation: M. Rostock et C. Unger, Utility of mistletoe therapy in cancer patients, INTERNIST, 39(12), 1998, pp. 1294-1295